台股 » 個股 » 和康生 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

和康生

(1783)
可現股當沖
  • 股價
    42.40
  • 漲跌
    ▲0.65
  • 漲幅
    +1.56%
  • 成交量
    93
  • 產業
    上市 生技醫療類股
  • 127人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
和康生 (1783)籌碼相關-臺銀證券 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw05/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1001/2202/1402/2603/1003/2004/0104/1404/2404/2630354045505560May '24Jul '24Sep '24Nov '24Mar '2560d90dAll

臺銀證券 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/16140.70140.8041.2002920.00%
2025/04/1500.00240.4040.60-2299-0.67%
2025/04/14239.7500.0039.7023140.64%
2025/04/1100.00038.0039.4003240.00%
2025/04/09435.6000.0036.1043331.20%
2025/04/08039.7500.0039.5003270.00%
2025/04/07539.0500.0039.3553281.52%
2025/04/0200.00343.3343.35-3322-0.93%
2025/04/01043.1000.0043.4003230.00%
2025/03/28044.9500.0045.6003190.00%
2025/03/240.145.3000.0044.900.13210.02%
2025/03/21045.8000.0045.3503210.00%
2025/03/19045.3000.0045.3003260.00%
2025/03/18045.6500.0045.8503300.00%
2025/03/10350.1700.0050.4033350.89%
2025/03/0600.00650.4050.90-6331-1.81%
2025/03/05649.9000.0049.6063241.85%
2025/03/0400.000.154.5053.70-0.1302-0.04%
2025/02/1100.000.250.2050.40-0.2272-0.07%
2025/02/100.251.8000.0051.600.22680.07%
2025/01/1000.00352.6351.70-3198-1.51%
2025/01/0900.00052.2052.300190-0.01%
2025/01/08251.65152.1051.7011840.54%
2025/01/07152.60152.8052.1001760.00%
2025/01/0600.00351.0050.80-3159-1.88%
2024/12/2700.00047.1048.650131-0.02%
2024/12/2600.000.147.0046.90-0.1128-0.05%
2024/11/27645.32645.0743.7001090.00%
2024/11/22243.85244.2544.0001090.00%
2024/11/19141.85142.2042.1501100.00%
2024/11/1800.00041.7541.9001110.00%
2024/11/08243.05243.3543.800120-0.01%
2024/11/0400.00042.0042.1001260.00%
2024/10/2900.00042.2542.300138-0.01%
2024/09/24042.2000.0042.1003790.00%
2024/09/200.142.6000.0042.750.13920.03%
2024/09/0600.00045.4045.5004060.00%
2024/09/0500.00045.2045.2504090.00%
2024/09/0200.00046.5046.5504140.00%
2024/08/2800.00046.5046.5504320.00%
2024/08/2700.00046.2046.5004320.00%
2024/08/2600.00046.1046.1004300.00%
2024/08/2300.00245.4046.10-2429-0.47%
2024/08/2200.00045.6045.6004290.00%
2024/08/21144.70244.9545.10-1430-0.23%
2024/08/19243.70243.7043.8004270.00%
2024/08/05038.1000.0038.1004120.00%
2024/08/0100.00243.9043.65-2403-0.50%
2024/07/30042.60343.3043.70-3402-0.74%
2024/07/26045.0000.0044.3003960.01%
2024/07/19548.8400.0046.5053841.31%
2024/07/18148.00147.8048.0003460.00%
2024/07/1700.00345.3044.90-3328-0.91%
2024/07/16344.75044.9544.7533280.91%
2024/07/10045.2500.0045.3503290.00%
2024/07/08347.82547.4047.00-2311-0.64%
2024/07/0500.00149.7049.40-1300-0.33%
2024/07/04149.40249.6049.55-1295-0.34%
2024/07/03350.7300.0050.4032841.05%
2024/07/02350.9300.0050.4032621.14%
2024/07/0100.001.247.5150.20-1.2214-0.57%
2024/06/27346.5300.0045.8531861.61%
2024/06/19145.7000.0045.7011660.60%
2024/06/1800.000.146.4046.35-0.1165-0.06%
2024/06/05544.70244.9044.9031531.96%
2024/06/041444.83245.2044.30121498.01%
2024/06/031342.5400.0042.60131379.42%
2024/05/2400.00142.1542.35-1136-0.73%
2024/05/17143.0000.0043.6011350.74%
〈大江集團法說〉和康生明年營收續拚雙位數成長 淨利率維持25%Anue鉅亨-2023/11/20
和康生三大業務銷售看旺 明、後年將啟動擴產計畫Anue鉅亨-2023/07/25
和康生全年毛利率有望維持67%水準 今年將取得10張認證Anue鉅亨-2023/05/23
和康生 相關文章